Search Results 451-460 of 1166 for Sökmotor Android 🔍 www.46.gg
About this study. Glaucoma is a major cause of blindness. The inability to predict a patient's IOP response to medications is a critical barrier for the ...
This multicenter, open-label, Phase I study will evaluate the safety, efficacy, and pharmacokinetics of atezolizumab alone or in combination with daratumumab ...
Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “I” to learn about drug side effects, proper use and ...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancer.
The aim of this feasibility study is to investigate whether we can improve sleep quality in patients who have DBS devices implanted for existing neurological ...
Principal Investigator: Scott P. Steinman, M.D.. Project Coordinator: Mark E. Zobitz — zobitz.mark@mayo.edu. Shoulder Range of Motion and Strength in the High ...
About this study. The purpose of this study is to assess the preliminary anti-tumor activity, safety, and tolerability, and to explore the pharmacokinetics ...
About this study. The purpose of the KAPP-Sen Tissue Mapping Center (TMC) Collaborative is an effort to characterize cellular senescence (cellular aging) in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to honor and celebrate the contributions of our world-class doctors.